Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP, Fibbe WE, van den Brink GR, Hommes DW.

Gut. 2010 Dec;59(12):1662-9. doi: 10.1136/gut.2010.215152. Epub 2010 Oct 4.

PMID:
20921206
2.

Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.

Syková E, Jendelová P, Urdzíková L, Lesný P, Hejcl A.

Cell Mol Neurobiol. 2006 Oct-Nov;26(7-8):1113-29. Epub 2006 Apr 22. Review.

PMID:
16633897
3.

Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD.

Ricart E.

Dig Dis. 2012;30(4):387-91. doi: 10.1159/000338134. Epub 2012 Jul 12. Review.

PMID:
22796802
4.

Mesenchymal stromal cell therapy for Crohn's disease.

Liew A, O'Brien T, Egan L.

Dig Dis. 2014;32 Suppl 1:50-60. doi: 10.1159/000367826. Epub 2014 Dec 17. Review.

PMID:
25531353
5.

Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells.

Voswinkel J, Francois S, Gorin NC, Chapel A.

Immunol Res. 2013 Jul;56(2-3):241-8. doi: 10.1007/s12026-013-8397-8. Review.

PMID:
23564182
6.

Role of mesenchymal stem cell therapy in Crohn's disease.

Dalal J, Gandy K, Domen J.

Pediatr Res. 2012 Apr;71(4 Pt 2):445-51. doi: 10.1038/pr.2011.56. Epub 2012 Feb 8. Review.

PMID:
22430380
7.

Mesenchymal Stromal Cell Therapy in Crohn's Disease.

Forbes GM.

Dig Dis. 2017;35(1-2):115-122. doi: 10.1159/000449091. Epub 2017 Feb 1. Review.

PMID:
28147367
8.

Treatment of inflammatory diseases with mesenchymal stem cells.

Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A.

Inflamm Allergy Drug Targets. 2009 Jun;8(2):110-23. Review.

PMID:
19530993
9.

Bone marrow transplantation: a new strategy for intractable diseases.

Ikehara S.

Drugs Today (Barc). 2002 Feb;38(2):103-11. Review.

PMID:
12532188
10.
11.

Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.

Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L, Chapel A.

Clin Rev Allergy Immunol. 2013 Oct;45(2):180-92. doi: 10.1007/s12016-012-8347-6. Review.

PMID:
23296948
12.

Overview of stem cell therapy for Crohn's disease.

Dryden GW.

Expert Opin Biol Ther. 2009 Jul;9(7):841-7. doi: 10.1517/14712590902956615. Review.

PMID:
19527107
13.

Stem cells as treatment in inflammatory bowel disease.

Hawkey CJ.

Dig Dis. 2012;30 Suppl 3:134-9. doi: 10.1159/000342740. Epub 2013 Jan 3. Review.

PMID:
23295704
14.

Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.

Yi T, Song SU.

Arch Pharm Res. 2012 Feb;35(2):213-21. doi: 10.1007/s12272-012-0202-z. Epub 2012 Feb 28. Review.

PMID:
22370776
15.

Remestemcel-L: human mesenchymal stem cells as an emerging therapy for Crohn's disease.

Mannon PJ.

Expert Opin Biol Ther. 2011 Sep;11(9):1249-56. doi: 10.1517/14712598.2011.602967. Epub 2011 Jul 25. Review.

PMID:
21787241
16.

Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation.

Stagg J, Galipeau J.

Curr Mol Med. 2013 Jun;13(5):856-67. Review.

PMID:
23642066
17.

Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.

Cao Y, Ding Z, Han C, Shi H, Cui L, Lin R.

Dig Dis Sci. 2017 Apr;62(4):851-860. doi: 10.1007/s10620-017-4453-x. Epub 2017 Feb 6. Review.

PMID:
28168575
18.

Stem cell transplantation as rescue therapy for refractory Crohn's disease: a sytematic review.

Labidi A, Serghini M, Ben Mustapha N, Fekih M, Boubaker J, Filali A.

Tunis Med. 2014 Nov;92(11):655-9. Review.

19.

Mesenchymal stromal cells: current understanding and clinical status.

Salem HK, Thiemermann C.

Stem Cells. 2010 Mar 31;28(3):585-96. doi: 10.1002/stem.269. Review.

20.

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.

Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ; Canadian Critical Care Trials Group..

PLoS One. 2012;7(10):e47559. doi: 10.1371/journal.pone.0047559. Epub 2012 Oct 25. Review.

Supplemental Content

Support Center